Exelixis
Delaware corporation
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 65 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
—
not enough monitored evidence
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 64 % · cci-v1
13 active sensors·2 observations·0 historical changes·0 structured events·historical coverage 100 %·observed since 2026-09-13
Compare Exelixis with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies
